A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.

MLA

Guillaumier, Stephanie, et al. “A Multicentre Study of 5-Year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.” European Urology, vol. 74, no. 4, Oct. 2018, pp. 422–29. EBSCOhost, https://doi.org/10.1016/j.eururo.2018.06.006.

APA

Guillaumier, S., Peters, M., Arya, M., Afzal, N., Charman, S., Dudderidge, T., Hosking-Jervis, F., Hindley, R. G., Lewi, H., McCartan, N., Moore, C. M., Nigam, R., Ogden, C., Persad, R., Shah, K., van der Meulen, J., Virdi, J., Winkler, M., Emberton, M., & Ahmed, H. U. (2018). A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. European Urology, 74(4), 422–429. https://doi.org/10.1016/j.eururo.2018.06.006

Chicago

Guillaumier, Stephanie, Max Peters, Manit Arya, Naveed Afzal, Susan Charman, Tim Dudderidge, Feargus Hosking-Jervis, et al. 2018. “A Multicentre Study of 5-Year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.” European Urology 74 (4): 422–29. doi:10.1016/j.eururo.2018.06.006.